Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-07-28

FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Detrol LA (tolterodine tartrate) submitted by Viatris Specialty LLC, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Detrol LA (tolterodine tartrate)

Snippet

SUPPL AP for DETROL LA (TOLTERODINE TARTRATE)